Quinfamide Market

Quinfamide Market Size, Share & Industry Analysis, By Source (Chemical Synthesis, Quinoline Derivatives, Halogenated Aromatic Intermediates), By End-User Industry (Pharmaceuticals, Gastroenterology Clinics, Infectious Disease Centers, Research Institutions), and Forecast, 2025–2035

The global Quinfamide market is projected to grow at a CAGR of 4.7% during the forecast period, driven by its established role in the treatment of intestinal parasitic infections, especially amoebiasis. Quinfamide is an antiamoebic agent widely used in both adult and pediatric formulations due to its favorable safety profile and single-dose regimen, which enhances treatment adherence and public health utility.

Regionally, North America currently dominates the market owing to a high burden of amoebic infections, widespread use in national deworming programs, and government-supported pharmaceutical distribution. The Asia-Pacific region is expected to experience the fastest growth, supported by improved access to antiparasitic drugs, increased awareness of gastrointestinal hygiene, and the growth of generic manufacturing facilities in countries like India and Indonesia.

The Quinfamide market report provides detailed insights into synthesis methods, production scalability, cost-effective formulations, and regional regulatory frameworks. As global focus intensifies on reducing the prevalence of neglected tropical diseases and improving sanitation-linked healthcare, Quinfamide continues to be a valuable API across pharmaceutical companies, gastroenterology clinics, infectious disease centers, and research institutions developing targeted therapies for protozoal infections.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Quinfamide
  • Key End-User Industrys & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Source
    • Chemical Synthesis
    • Quinoline Derivatives
    • Halogenated Aromatic Intermediates
  • Key End-User Industry
  • Pharmaceuticals
  • Gastroenterology Clinics
  • Infectious Disease Centers
  • Research Institutions
  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Trade Analysis
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America, and Middle East, and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Production Capacity
  • Company Profiles & Key Developments
    • SimSon Pharma Limited
    • Clearsynth Labs Ltd.
    • LGM Pharma
    • TCI Chemicals Pvt. Ltd.
    • Jubilant Ingrevia Ltd.
    • Enaltec Labs Pvt. Ltd.
    • Shreeji Pharma International
    • Hangzhou FandaChem Co., Ltd.
    • Wuhan Fortuna Chemical Co., Ltd.
    • Suven Pharmaceuticals Ltd.
    • Spectrum Chemical Mfg. Corp.
    • Laurus Labs
    • Aarti Drugs Ltd.
    • Merck KGaA (MilliporeSigma)
    • Kingchem Life Science
    • Amadis Chemical Co., Ltd.
    • Angene International Ltd.
    • Pharmaffiliates Analytics & Synthetics
    • BOC Sciences
    • Shanghai Jinlan Chemical Co., Ltd.
  • Mergers, Acquisitions & Investments
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is a Quinfamide?
Quinfamide is an antiprotozoal API primarily used for the treatment of intestinal amoebiasis. It is effective against Entamoeba histolytica, offering a single-dose regimen with minimal side effects, making it especially suitable for mass deworming and public health programs in endemic regions.
What is the market size for Quinfamide?
The Quinfamide API market is growing at a CAGR of 4.7% during the forecast period from 2025 to 2035, supported by sustained global demand for gastrointestinal antiparasitic therapies.
What are the drivers for the Quinfamide Market?
Key drivers include high prevalence of parasitic infections in developing countries, inclusion in national deworming campaigns, improved access to essential medicines, and expansion of cost-effective generic drug production.
Who are the key players operating in the Quinfamide Market?
Major players include SimSon Pharma, Clearsynth Labs, LGM Pharma, TCI Chemicals, Jubilant Ingrevia, Enaltec Labs, and Shreeji Pharma International.
Which region would exhibit the fastest growth in the Quinfamide Market?
The Asia-Pacific region is expected to witness the fastest growth due to rising awareness of gastrointestinal health, government-led infection control initiatives, and increased production capacity in countries like India, China, and Indonesia.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.